医学
胆总管
胆囊切除术
内镜逆行胰胆管造影术
胆管
外科
胰腺炎
胆囊炎
普通外科
胆囊结石
胆囊
急性胰腺炎
作者
Antti Kivivuori,Laura Mattila,Antti Siiki,Johanna Laukkarinen,Tuomo Rantanen,Mika Ukkonen
标识
DOI:10.1097/ta.0000000000003852
摘要
BACKGROUND Older patients with simultaneous main bile duct and gallbladder stones, especially those with high-surgical risks, create a common clinical dilemma. After successful endoscopic removal of main bile duct stones, should these patients undergo laparoscopic cholecystectomy to reduce risk of recurrent biliary events? In this population-based cohort study, we report long-term outcomes of a wait-and-see strategy after successful endoscopic extraction of main bile duct stones. METHODS Consecutive patients 75 years or older undergoing endoscopic stone extraction without subsequent cholecystectomy in two tertiary academic centers between January 2010 and December 2018 were included. Primary outcome measure was recurrence of biliary events. Secondary outcome measures were operation-related morbidity and mortality. RESULTS A total of 450 patients (median age, 85 years; 61% female) were included, with a median follow-up time of 36 months (0–120 months). Recurrent biliary events occurred in 51 patients (11%), with a median time from index hospital admission to recurrence of 307 days (12–1993 days). The most common biliary event was acute cholecystitis (7.1%). Twelve patients had cholangitis (2.7%) and two biliary pancreatitis (0.4%). Only one patient (0.4%) underwent surgery due to later gallstone-related symptoms. Eighteen patients (4.0%) required endoscopic intervention and 16 (3.5%) underwent surgery. There were no operation-associated deaths or morbidity among those undergoing later surgical or endoscopic interventions. CONCLUSION In elderly patients, it is relatively safe to leave gallbladder in situ after successful sphincterotomy and endoscopic common bile duct stone removal. In elderly and frail patients, a wait-and-see strategy without routine cholecystectomy rarely leads to clinically significant consequences. LEVEL OF EVIDENCE Therapeutic/Care Management; Level III.
科研通智能强力驱动
Strongly Powered by AbleSci AI